详细指南即将推出
我们正在为Body Recomposition on GLP-1 Calculator编写全面的教育指南。请尽快回来查看逐步解释、公式、真实案例和专家提示。
The Body Recomposition on GLP-1 Calculator tracks and optimizes the ratio of fat loss to lean mass preservation during GLP-1 receptor agonist therapy. Body recomposition refers to the simultaneous loss of fat and preservation (or gain) of muscle tissue, resulting in improved body composition even when scale weight changes are modest. This is the gold standard outcome for weight loss therapy because it maximizes metabolic health, physical function, and aesthetic results. The challenge with GLP-1 medications is that their potent appetite suppression can lead to significant caloric deficits that promote lean mass catabolism alongside fat loss. In the STEP 1 DEXA substudy, semaglutide 2.4 mg patients lost approximately 39 percent of their weight as lean mass. However, this ratio is highly modifiable through protein optimization and resistance training, and patients who implement both strategies can achieve body recomposition ratios where 75 to 85 percent of weight lost is fat. This calculator integrates body composition measurements (from DEXA, bioimpedance, or estimates based on anthropometric data) with nutritional and exercise inputs to generate a body recomposition score, track progress over time, and provide actionable recommendations for improving the fat-to-lean ratio. It serves as the central dashboard for patients and clinicians who view weight loss as a body composition optimization problem rather than simply a scale weight reduction goal. The tool is used by obesity medicine specialists monitoring body composition outcomes, exercise physiologists designing resistance programs for GLP-1 patients, registered dietitians fine-tuning macronutrient ratios, and patients who want objective feedback on whether their weight loss is primarily fat or includes concerning amounts of lean mass loss.
Body Recomposition Score = (Fat Mass Lost / Total Weight Lost) x 100, where a score above 75 is good, above 80 is excellent, and below 65 indicates excessive lean mass loss. Fat Mass Lost = (Starting Body Fat % x Starting Weight) - (Current Body Fat % x Current Weight). Lean Mass Change = Total Weight Lost - Fat Mass Lost. For a worked example: patient started at 220 lbs, 42% body fat (92.4 lbs fat, 127.6 lbs lean). Now 185 lbs, 35% body fat (64.75 lbs fat, 120.25 lbs lean). Fat lost = 92.4 - 64.75 = 27.65 lbs. Lean lost = 127.6 - 120.25 = 7.35 lbs. Total lost = 35 lbs. Score = 27.65/35 x 100 = 79.0 (good).
- 1Enter your starting body composition data including weight and body fat percentage. Body fat percentage can come from a DEXA scan (most accurate), bioelectrical impedance scale (moderately accurate but consistent for tracking trends), skinfold calipers, or a visual estimate using reference photos. If you do not have a direct measurement, the calculator estimates body fat percentage using the Navy method based on waist, neck, and hip circumferences.
- 2Enter your current body composition measurements using the same method as your baseline. Consistency in measurement method is more important than absolute accuracy because the calculator tracks changes over time. If you used a bioimpedance scale at baseline, use the same scale under the same conditions (morning, fasted, hydrated) for follow-up measurements.
- 3The calculator computes your body recomposition score along with absolute fat mass lost, absolute lean mass change, and comparative percentiles from clinical trial data and optimization studies. A score above 75 means more than three-quarters of your weight loss is fat, which is considered a good outcome. A score above 80 with active resistance training is excellent and approaches the theoretical optimum.
- 4Review the contributing factors analysis which identifies what is driving your current score. The three primary modifiable factors are protein intake (targeting 1.2 to 1.6 g/kg/day), resistance training frequency (targeting 2 to 3 sessions per week), and rate of weight loss (targeting 0.5 to 1.0 percent of body weight per week). The calculator shows which of these factors is strongest and weakest in your current regimen.
- 5The longitudinal tracking feature plots your fat mass and lean mass separately over time, showing the trajectories diverging (fat decreasing while lean stays stable or decreases less rapidly). This visualization is particularly powerful for patients whose scale weight has plateaued but whose body composition is still improving, a common and encouraging phenomenon during resistance-training-augmented GLP-1 therapy.
- 6Generate a personalized optimization plan with specific targets for protein, exercise, and caloric intake that will maximize your recomposition score over the next 4 to 8 weeks. The plan includes meal templates, workout recommendations, and tracking checkpoints. Patients who follow the optimization plan typically improve their recomposition score by 5 to 15 points over 8 weeks.
- 7The waist-to-hip ratio and waist circumference trend are tracked alongside the body composition data because these metrics reflect visceral fat loss, which is the most metabolically significant component of fat reduction. GLP-1 medications preferentially reduce visceral fat, and tracking waist circumference often reveals continued improvement even when total weight is stable.
This patient implemented the full body recomposition protocol from the start: high protein intake, consistent resistance training, and moderate weight loss pace. Only 4 lbs of lean mass was lost out of 40 total, achieving a near-optimal body composition outcome.
Without protein optimization or resistance training, this patient lost over 10 lbs of lean mass, accounting for 30 percent of total weight loss. This level of lean mass loss reduces metabolic rate, weakens physical function, and increases weight regain risk.
This patient has gained 5.7 lbs of lean mass while losing 8.7 lbs of fat, resulting in only 3 lbs of scale weight change. The recomposition score exceeds 100 because lean mass actually increased. This is the ideal outcome of GLP-1 therapy combined with dedicated resistance training and high protein.
Obesity medicine clinics that invest in DEXA body composition scanners use recomposition tracking as a key quality metric for their GLP-1 programs. Programs that achieve average recomposition scores above 75 can demonstrate superior outcomes compared to medication-only approaches, supporting their value proposition for insurance contracting and patient marketing.
Fitness facilities and personal training studios specializing in GLP-1 patient populations use body recomposition as their primary outcome measure rather than scale weight. By demonstrating improvements in body fat percentage, muscle mass, and functional strength, these programs justify their fees and maintain client engagement even during periods when scale weight is stable.
Research institutions conducting clinical trials of GLP-1 medications are increasingly including DEXA body composition as a secondary or co-primary endpoint rather than relying solely on scale weight. The FDA has signaled interest in body composition outcomes for future anti-obesity medication approvals, reflecting the growing recognition that the quality of weight loss matters as much as the quantity.
Patients themselves use recomposition tracking as motivation and validation. Seeing objective data showing that their body composition is improving, even when the scale is not moving, provides powerful reinforcement for maintaining the resistance training and high-protein diet that are essential but often difficult to sustain long-term.
Post-menopausal women face accelerated lean mass loss during weight loss
Post-menopausal women face accelerated lean mass loss during weight loss because declining estrogen levels reduce muscle protein synthesis rates and promote visceral fat accumulation. These patients may need even higher protein targets (1.5 to 1.8 g/kg/day) and more frequent resistance training to achieve acceptable recomposition scores. Hormone replacement therapy, when appropriate, may provide additional lean mass protection.
Patients with lipedema (abnormal fat deposition in the legs and arms that is
Patients with lipedema (abnormal fat deposition in the legs and arms that is resistant to diet and exercise) may see disproportionate fat loss from the trunk and visceral compartments while lipedema-affected areas show minimal change. Body composition measurements in these patients should focus on trunk fat and waist circumference rather than total body fat percentage, which may appear to improve less than expected due to the resistant lipedema fat deposits.
| Category | Male Body Fat % | Female Body Fat % | Health Risk |
|---|---|---|---|
| Essential Fat | 2-5% | 10-13% | Below this is dangerous |
| Athletic | 6-13% | 14-20% | Very low risk |
| Fit | 14-17% | 21-24% | Low risk |
| Average | 18-24% | 25-31% | Moderate risk |
| Obese | 25%+ | 32%+ | Elevated risk |
| Severely Obese | 35%+ | 42%+ | High risk |
What is the ideal ratio of fat to muscle loss during GLP-1 therapy?
The ideal ratio is at least 75 to 80 percent fat loss and no more than 20 to 25 percent lean mass loss. With optimal protein intake (1.4 to 1.6 g/kg/day) and resistance training (2 to 3 times per week), some patients achieve ratios of 85 percent fat loss. In rare cases with dedicated strength training, patients can actually gain lean mass while losing fat on GLP-1 medication, achieving true body recomposition where 100 percent or more of the weight lost is fat.
Can I build muscle while on GLP-1 medication?
Yes, it is possible to build muscle while on GLP-1 medication, particularly for patients who are new to resistance training (the 'newbie gains' effect). The caloric deficit from GLP-1 appetite suppression works against muscle building, but adequate protein intake (1.6 g/kg or higher), a well-designed progressive resistance training program, sufficient sleep (7 to 9 hours), and creatine supplementation can overcome this deficit to some extent. True muscle gain on GLP-1 medication is most likely in the first 6 to 12 months of combined drug and resistance training therapy.
How should I measure body composition?
DEXA (dual-energy X-ray absorptiometry) is the gold standard for body composition measurement, providing accurate fat mass, lean mass, and bone density data. It costs $75 to $200 per scan and is available at many imaging centers. Bioelectrical impedance scales ($30 to $300 for consumer models) are less accurate in absolute terms but provide consistent relative measurements when used under standardized conditions. For simple tracking, waist circumference with a measuring tape is free, highly reproducible, and correlates well with visceral fat changes.
How often should I measure body composition?
Body composition should be assessed every 8 to 12 weeks, which provides enough time for meaningful changes to occur while being frequent enough to detect trends and adjust interventions. More frequent measurement (weekly) creates noise from normal biological fluctuations and measurement variability that can obscure real trends. DEXA scans every 3 to 6 months provide the highest-quality longitudinal data. Bioimpedance can be used monthly under standardized conditions.
Does body recomposition slow down scale weight loss?
Yes, and this is a positive sign rather than a problem. When a patient gains 3 lbs of muscle while losing 8 lbs of fat, the scale shows only 5 lbs of total weight loss. But the 8 lbs of fat loss represents a much greater health improvement than 8 lbs of mixed fat and muscle loss. Patients and providers should celebrate the improved body composition rather than lamenting the slower scale movement. Tracking body composition alongside scale weight resolves this apparent contradiction.
专业提示
Take progress photos every 4 weeks under consistent lighting and posing conditions. Body recomposition is often visible in photos before it shows on the scale or even in body composition measurements. Side-by-side comparison photos showing reduced waist size, more visible muscle definition, or improved posture provide powerful visual evidence of body composition improvement that complements the numerical data from the calculator.
你知道吗？
In a landmark study by Longland and colleagues at McMaster University, participants on a severe caloric deficit (40 percent below maintenance) who combined high protein intake (2.4 g/kg/day) with intense resistance training actually gained 2.6 lbs of lean mass while losing 10.5 lbs of fat over 4 weeks. This proved that body recomposition is physically possible even in a significant energy deficit, as long as protein and training stimulus are sufficient.